Treatment of fibroadenomatosis in 14 cats with aglepristone - Changes in blood parameters and follow-up

Veterinary Record

Volumn 165, Issue 22, 2009, Pages 657-660

  Jurka, P ^a   Max, A ^a  

^a WARSAW UNIVERSITY OF LIFE SCIENCES   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 73949090538     PISSN: 00424900     EISSN: None     Source Type: Journal    
DOI: 10.1136/vr.165.22.657     Document Type: Article

References (15)

1. BORYCZKO, Z., GIZIŃSKI, S., SEWERYN, T. & BOSTEDT, H. (2006) Feline fibroepithelial hyperplasia of mammary gland: antigestagens therapy. Medycyna Weterynaryjna 62, 62-63 (In Polish)
2. GÖRLINGER, S., KOOISTRA, H. S., VAN DEN BROEK, A. & OKKENS, A. C. (2002) Treatment of fibroadenomatous hyperplasia in cats with aglepristone. Journal of Veterinary Internal Medicine 16, 710-713
3. GUDERMUTH, D. F., NEWTON, L., DAELS, P. & CONCANNON, P. (1997) Incidence of spontaneous ovulation in young, group-housed cats based on serum and faecal concentrations of progesterone. Journal of Reproduction and Fertility 51 (Suppl), 177-184
4. LAWLER, D. F., JOHNSTON, S. D., HEGSTAD, R. L., KELTNER, D. G. & OWNES, S. F. (1993) Ovulation without cervical stimulation in domestic cats. Journal of Reproduction and Fertility 47 (Suppl), 57-61
5. LORETTI, A. P., ILHA, M. R., ORDAS, J. & MARTIN, M. J. (2005) Clinical, pathological and immunohistochemical study of feline mammary fibroepithelial hyperplasia following a single injection of depot medroxyprogesterone acetate. Journal of Feline Medicine and Surgery 7, 43-52
6. MACDOUGALL, L. D. (2003) Mammary fibroadenomatous hyperplasia in a young cat attributed to treatment with megastrol acetate. Canadian Veterinary Journal 44, 227-229
7. MARTIN, M. J., MILLAN, Y., BAUTISTA, M. J., PEREZ, J. & CARRSCO, L. (2000) Oestrogen and progesterone receptors in feline fibroadenomatous change: an immunohistochemical study. Research in Veterinary Science 68, 15-21
8. MEISL, D., HUBLER, M. & ARNOLD, S. (2003) Der Progesteronantagonist Aglépristone (Alizine) zur Behandlung der fibroepithelialen Hyperplasie der Mamma bei der Katze. Schweizer Archiv Für Tierheilkunde 145, 130-136
9. MILLANTA, F., CALANDRELLA, M., BARI, G., NICCOLINI, M., VANNOZZI, I. & POLI, A. (2005) Comparison of steroid receptor expression in normal, dysplastic, and neoplastic canine and feline mammary tissues. Research in Veterinary Science 79, 225-232
10. MISDORP, W., ELSE, R. W., HELLMEN, E. & LIPSCOMB, T. P. (1999) Histological classification of mammary tumours of the dog and the cat. International Histological Classification of Tumours of Domestic Animals, 2nd series. Bulletin of the World Health Organization/American Registry of Pathology, pp 18-25
11. MOL, J. A., VAN GARDEN, E. & RYTTEMAN, G. R. (1996) New insights in the molecular mechanism of progestin-induced proliferation of mammary epithelium: induction of the local biosynthesis of growth hormone (GH) in the mammary glands of dogs, cats and humans. Journal of Steroid Biochemistry and Molecular Biology 57, 67-71
12. PATRICELLI, A. J., LAPPIN, M. R. & STEYN, P. F. (1999) Mammary gland uptake of sodium Tc-pettechnetate in a cat with a drug-induced gynecomastia. Veterinary Radiology and Ultrasound 40, 87-88
13. RIJNBERK, A. & MOL, J. A. (1997) Progestin-induced hypersecretion of growth hormone: an introductory review. Journal of Reproduction and Fertility 51 (Suppl), 335-338
14. WEHREND, A., HOSPES, R. & GRUBER, A. D. (2001) Treatment of feline mammary fibroadenomatous hyperplasia with a progesterone-antagonist. Veterinary Record 148, 346-347
15. WINNICKA, A. (2004) Wartości referencyjne podstawowych badah laboratoryjnych w weterynarii. SGGW. pp 14-26